miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1 [Retraction]

Abstract

Wang M, Wu Q, Fang M, Huang W, Zhu H. Onco Targets Ther. 2019;12:9513–9525. We, the Editor and Publisher of Onco Targets and Therapy are retracting the published article. Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors have been unable to address the concerns raised and have not been able to provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors listed in this publication have been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Keywords

• glioblastoma
• mir-152-3p
• sos1
• cisplatin